International Reference Pricing Across Medicare and Medicaid

Key Points

• This viewpoint explores the potential effects of international reference pricing on drug pricing in the US.
• Discussion of three CMS drug pricing models
• Analysis of international reference pricing implications
• Evaluation of consumer and manufacturer perspectives
• International reference pricing may lead to lower drug costs for consumers.
• Manufacturers could face challenges adapting to new pricing models.
• Drug pricing policies may shift significantly as a result of these changes.